The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions · continued

Common supplements people ask about, assessed one at a time — a second dataset posts 91–105

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

LD
l.dziedzicTL2 Moderator21 Apr 2026#91

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

5 likes 3mo
KR
k.roosTL2 Moderator23 Apr 2026#92

This follows post #89 rather than contradicting it.

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

0 likes 3mo
AW
a.weissTL2 Moderator24 Apr 2026#93
n.duarte, post #89: post #88 answers the question as asked. The question underneath it is different. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches. Go to post

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

0 likes in reply to #89 3mo
AA
a.almeidaTL2 Moderator26 Apr 2026#94

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

19 likes 3mo
PS
p.silvaTL2 Moderator27 Apr 2026#95

Coming back to post #93, because the follow-up matters more than the original answer.

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

8 likes 3mo
EK
e.kimaniTL2 Moderator29 Apr 2026#96
e.roos, post #28: Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive. Go to post

Picking up post #93: that is the part I would want checked first.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

2 likes in reply to #28 3mo
K
KnowltonTL3Regular1 May 2026#97

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

0 likes 3mo
IB
i.brobergTL2 Moderator2 May 2026 · edited#98

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

26 likes 3mo
V
VThorvaldsenTL3Regular4 May 2026#99

I read post #97 twice before replying, because I had assumed the opposite.

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

0 likes 3mo
TL
t.lindqvistTL2 Moderator5 May 2026#100

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

0 likes 3mo
TK
t.karlsenTL2 Moderator7 May 2026#101
p.silva, post #95: Coming back to post #93, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it. Go to post

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

5 likes in reply to #95 3mo
WN
w.novakTL3Regular8 May 2026#102
k.kuusela, post #73: Coming back to post #71, because the follow-up matters more than the original answer. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches. Go to post

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

1 like in reply to #73 3mo
HE
h.espinozaTL2 Moderator10 May 2026#103

I read post #101 twice before replying, because I had assumed the opposite.

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

0 likes 3mo
ST
slow_titratorTL2Regular11 May 2026#104

This follows post #101 rather than contradicting it.

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

21 likes 3mo
RF
ro.friskTL2 Moderator13 May 2026#105
i.boateng, post #6: Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management. Go to post

On post #101 — agreed on the reasoning, with one qualification.

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

9 likes in reply to #6 3mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Follow-up: Oral contraceptives and delayed emptying: what the data shows
Oral contraceptives and delayed emptying: what the data shows — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is…
KMPEHBMSRL+31 35 13k 18mo
A widely repeated interaction claim that turns out to be unsupported — what changed since
A widely repeated interaction claim that turns out to be unsupported — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on…
GVANGAKAK+89 94 5.9k 2h
Sulfonylureas: the interaction most worth taking seriously — what changed since
On the subject in the title: Sulfonylureas: the interaction most worth taking seriously — what changed since Working notes rather than a conclusion. I have read the maintained page on this and I still have a…
TWMDNSNGSD+3 7 35k 1d
Follow-up: Reading an interaction checker output critically
Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I am asking rather…
MNWVSGSR+62 66 13k 2d
Sulfonylureas: the interaction most worth taking seriously
Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
DOZCERFHKR+4 8 38k 6h

Related topics — sharing the tags delayed gastric emptying, insulin, needs a source

TopicParticipantsRepliesViewsActivity
Why plausible mechanism is not evidence of effect — one year on
The question in the title: Why plausible mechanism is not evidence of effect — one year on I will give what I have already checked below so nobody repeats it. Session topic: STEP 4 ( JAMA , 2021). Please read…
FNPNMBUCIL+3 7 3.6k 13mo
What would change my mind about repair peptides: a specific answer — one year on
What would change my mind about repair peptides: a specific answer — one year on I have a specific reason for asking rather than idle curiosity, and the context is below. Session topic: STEP 1 ( N Engl J Med…
CTLLFVON+9 13 42k 19mo
Coming back to: Grapefruit: why this class is not the class that cares
Posting this under the heading it deserves: Grapefruit: why this class is not the class that cares Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so…
AKHEYMJFCL+44 48 12k 18mo
Revisiting: What a well-designed human trial of a secretagogue would look like
On the subject in the title: Revisiting: What a well-designed human trial of a secretagogue would look like Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it…
HBSBOIDAS+69 74 25k 18mo
Naming conventions for research peptides and the confusion they cause — one year on
Naming conventions for research peptides and the confusion they cause — one year on — setting out what I have, and where I think it stops being reliable. I have seen SURMOUNT-2 ( Lancet , 2023) cited in…
CPLCVSMSCV+1 5 181 2y